Study #2022-0418
Optimizing the Use of Ketamine to Reduce Chronic Postsurgical Pain
MD Anderson Study Status
Enrolling
Treatment Agent
Continuous ketamine infusion, Ketamine + Saline
Description
The study utilizes a 3-arm placebo-controlled RCT to study the effectiveness of ketamine in reducing chronic post-mastectomy pain. Participants randomized to the first arm will receive a 0.35 mg/kg dose after induction, followed by a 0.25 mg/kg/hr infusion during surgery (up to a maximum of 6 hours) and continued for 2 hours postoperatively. Participants in the second arm will receive a single dose of 0.6 mg/kg of ketamine in the post-anesthesia care unit, and the final group will serve as the control group and receive saline (no ketamine).
Resources and Links
Phone Number: 1-877-MDA-6789
Information and next steps
Disease:
Chronic Postsurgical Pain
Study phase:
Phase III
Physician name:
Juan Cata
Department:
Anesthesiology & PeriOper Med
For general questions about clinical trials:
1-855-319-9556
Help #EndCancer
Give Now
Donate Blood
Our patients depend on blood and platelet donations.
Shop MD Anderson
Show your support for our mission through branded merchandise.